 Regression left ventricular hypertrophy hypertensive heart transplant recipients enalapril furosemide verapamil BACKGROUND prospective study left ventricular LV hypertrophy transplanted heart medical therapy time course process effect exercise capacity myocardial function cardiac hemodynamics METHODS RESULTS Ten hypertensive heart transplant recipients LV hypertrophy therapy enalapril furosemide verapamil initial blood pressure BP control months noninvasive ambulatory BP monitoring M-mode two-dimensional echocardiography supine bicycle ergometry Average systolic diastolic BP mm Hg mm Hg initial BP control total peripheral resistance normal Exercise capacity unchanged study LV mass mass-to-volume ratio end-diastolic septal posterior wall thickness g/ml mm g/ml mm months g/ml mm months unaltered months correlation decrease average mean BP LV mass months antihypertensive therapy Systolic meridional wall stress LV end-diastolic stroke volume ejection fraction cardiac output unchanged observation period CONCLUSIONS results regression LV hypertrophy effective antihypertensive therapy denervated transplanted heart extent decrease average BP main determinant extent reduction LV mass LV afterload systolic meridional wall stress LV size pump function physical exercise capacity transplant patients therapeutic regimen study